Style | Citing Format |
---|---|
MLA | Vahabi SM, et al.. "Jak Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? a Systematic Review of the Published Literature." Cancers, vol. 16, no. 5, 2024, pp. -. |
APA | Vahabi SM, Bahramian S, Esmaeili F, Danaei B, Kalantari Y, Fazeli P, Sadeghi S, Hajizadeh N, Assaf C, Etesami I (2024). Jak Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? a Systematic Review of the Published Literature. Cancers, 16(5), -. |
Chicago | Vahabi SM, Bahramian S, Esmaeili F, Danaei B, Kalantari Y, Fazeli P, Sadeghi S, Hajizadeh N, Assaf C, Etesami I. "Jak Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? a Systematic Review of the Published Literature." Cancers 16, no. 5 (2024): -. |
Harvard | Vahabi SM et al. (2024) 'Jak Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? a Systematic Review of the Published Literature', Cancers, 16(5), pp. -. |
Vancouver | Vahabi SM, Bahramian S, Esmaeili F, Danaei B, Kalantari Y, Fazeli P, et al.. Jak Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? a Systematic Review of the Published Literature. Cancers. 2024;16(5):-. |
BibTex | @article{ author = {Vahabi SM and Bahramian S and Esmaeili F and Danaei B and Kalantari Y and Fazeli P and Sadeghi S and Hajizadeh N and Assaf C and Etesami I}, title = {Jak Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? a Systematic Review of the Published Literature}, journal = {Cancers}, volume = {16}, number = {5}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Vahabi SM AU - Bahramian S AU - Esmaeili F AU - Danaei B AU - Kalantari Y AU - Fazeli P AU - Sadeghi S AU - Hajizadeh N AU - Assaf C AU - Etesami I TI - Jak Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? a Systematic Review of the Published Literature JO - Cancers VL - 16 IS - 5 SP - EP - PY - 2024 ER - |